Imagen de Portada

An Estimator-Robust Design for Augmenting Randomized Controlled Trial with External Real-World Data

Fuente: arXiv

Guardado en:

Detalles Bibliográficos
Autores principales:	Qiu, Sky, Tarp, Jens, Mertens, Andrew, van der Laan, Mark
Formato:	Preprint
Publicado:	2025
Materias:	Methodology Applications
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Adaptive-TMLE for the Average Treatment Effect based on Randomized Controlled Trial Augmented with Real-World Data
por: van der Laan, Mark, et al.
Publicado: (2024)

Considerations for the Integration of Randomized Controlled Trials and Real-World Data
por: Qiu, Sky, et al.
Publicado: (2026)

Improving the Efficiency of Subgroup Analysis in Randomized Controlled Trials with TMLE
por: Qiu, Sky, et al.
Publicado: (2026)

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
por: Phillips, Rachael V., et al.
Publicado: (2024)

Longitudinal Targeted Minimum Loss-based Estimation with Temporal-Difference Heterogeneous Transformer
por: Shirakawa, Toru, et al.
Publicado: (2024)

HAL-Based Plug-in Estimation with Pointwise Asymptotic Normality of the Causal Dose-Response Curve
por: Shi, Junming, et al.
Publicado: (2024)

Causal-ICM: A Data Fusion Framework For Heterogeneous Treatment Effect Estimation With Multi-Task Gaussian Processes
por: Dimitriou, Evangelos, et al.
Publicado: (2024)

Designing Efficient Hybrid and Single-Arm Trials: External Control Borrowing and Sample Size Calculation
por: Gao, Yujing, et al.
Publicado: (2025)

Index Date Imputation For Survival Outcomes for Externally Controlled Trials
por: Coent, Q. Le, et al.
Publicado: (2025)

Practical considerations for specifying a super learner
por: Phillips, Rachael V., et al.
Publicado: (2022)

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
por: Mao, Guangcai, et al.
Publicado: (2025)

Covariate Ordered Systematic Sampling as an Improvement to Randomized Controlled Trials
por: Jobson, Deddy, et al.
Publicado: (2024)

Regularized Targeted Maximum Likelihood Estimation in Highly Adaptive Lasso Implied Working Models
por: Li, Yi, et al.
Publicado: (2025)

TAD-SIE: Sample Size Estimation for Clinical Randomized Controlled Trials using a Trend-Adaptive Design with a Synthetic-Intervention-Based Estimator
por: Lala, Sayeri, et al.
Publicado: (2024)

Error-Controlled Borrowing from External Data Using Wasserstein Ambiguity Sets
por: Kimura, Yui, et al.
Publicado: (2026)

Augmented Doubly Robust Post-Imputation Inference for Proteomic Data
por: Moon, Haeun, et al.
Publicado: (2024)

Identifying and Estimating Causal Direct Effects Under Unmeasured Confounding
por: Boileau, Philippe, et al.
Publicado: (2026)

Flexible Approach for Statistical Disclosure Control in Geospatial Data
por: Skøien, Jon Olav, et al.
Publicado: (2024)

Implementing Response-Adaptive Randomisation in Stratified Rare-disease Trials: Design Challenges and Practical Solutions
por: Das, Rajenki, et al.
Publicado: (2024)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
por: Lee, Kyong Ju, et al.
Publicado: (2025)

Comparison of Simulation-Guided Design to Closed-Form Power Calculations in Planning a Cluster Randomized Trial with Covariate-Constrained Randomization: A Case Study in Rural Chad
por: Park, Jay JH, et al.
Publicado: (2025)

Automatic Quality Control for Agricultural Field Trials -- Detection of Nonstationarity in Grid-indexed Data
por: Wolf, Karen, et al.
Publicado: (2025)

Bayesian Spatial Point Process Modeling for Cluster Randomized Trials
por: Lee, Jooyeon, et al.
Publicado: (2025)

Cost Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials
por: Montoya, Lina M., et al.
Publicado: (2025)

A General Framework for Design-Based Treatment Effect Estimation in Paired Cluster-Randomized Experiments
por: Mann, Charlotte Z., et al.
Publicado: (2024)

Modeling Time-Varying Effects of Mobile Health Interventions Using Longitudinal Functional Data from HeartSteps Micro-Randomized Trial
por: Yu, Jiaxin, et al.
Publicado: (2024)

Statistical Design of Pragmatic Trials Using Electronic Health Record Data when Outcome Assessments are Uncontrolled and Irregular
por: Bobb, Jennifer F., et al.
Publicado: (2026)

Improving the Estimation of Site-Specific Effects and their Distribution in Multisite Trials
por: Lee, JoonHo, et al.
Publicado: (2023)

Bayesian Design and Analysis of Precision Trials with Partial Borrowing
por: Golchi, Shirin, et al.
Publicado: (2026)

Two-stage Adaptive Design Cluster Randomised Trials
por: Watson, Samuel I., et al.
Publicado: (2026)

A Bayesian Framework for Latent Compliance Modeling in Cluster Randomized Trials with One-Sided Noncompliance
por: Sisti, Anthony, et al.
Publicado: (2025)

Unified and Simple Sample Size Calculations for Individual or Cluster Randomized Trials with Skewed or Ordinal Outcomes
por: Tu, Shengxin, et al.
Publicado: (2025)

Identifying Treatment Effect Heterogeneity with Bayesian Hierarchical Adjustable Random Partition in Adaptive Enrichment Trials
por: Zhao, Xianglin, et al.
Publicado: (2025)

A Flexible Model for Record Linkage
por: Robach, Kayané, et al.
Publicado: (2024)

Efficient Targeted Maximum Likelihood Estimators for Two-Phase Design Problems
por: Qiu, Sky, et al.
Publicado: (2026)

Inspection-Guided Randomization: A Flexible and Transparent Restricted Randomization Framework for Better Experimental Design
por: Wang, Maggie, et al.
Publicado: (2024)

Simulation-Guided Planning of a Target Trial Emulated Cluster Randomized Trial for Mass Small-Quantity Lipid Nutrient Supplementation Combined with Expanded Program on Immunization in Rural Niger
por: Alam, Shomoita, et al.
Publicado: (2025)

Robust Functional Principal Component Analysis for Non-Euclidean Random Objects
por: Xu, Jiazhen, et al.
Publicado: (2023)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
por: Komaki, Moka, et al.
Publicado: (2025)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
por: Chen, Yuxuan, et al.
Publicado: (2026)